[hpc-announce] Springer Book: call for chapters, COVID-19 and related, due on 1 Aug 2021

Victor Chang vic1e09 at soton.ac.uk
Mon May 3 15:39:44 CDT 2021

Dear colleagues,

I hope you can consider submitting book chapters due on 1 August. Springer is a well-known publisher. Many thanks in advance.

Thanks and regards,


Springer COVID19_Book 2021: Artificial Intelligence and Machine Learning Methods in


Call for Book Chapters
(submit to https://easychair.org/conferences/?conf=covid19-book2021):

The most severe issue that concerns the world during this period is the outbreak of the novel Coronavirus (COVID-19). The rapid spread of the virus around the world poses a real threat to all countries, as a result of that, researchers must pay attention to studying the details of this calamity. COVID-19 symptoms may be similar to other viral chest diseases in some of the symptoms that may cause the doctor's uncertainty in making the correct diagnosis decision due to the novelty of this virus. The recent diagnosis of COVID-19 is based on real-time reverse-transcriptase polymerase chain reaction (RT-PCR), and regarded as the gold standard for confirmation of infection. It has already been widely recognized that deep learning techniques can potentially have a substantial role in streamlining and accelerating the diagnosis of COVID-19 patients. Numerous open dataset enterprises have been set up over the past weeks to aid the researchers in developing and improving methods that could contribute to countering the Corona pandemic. To report the above unique problems in the diagnosis of COVID-19, various techniques need to be developed. This book focuses on novel analysis techniques related to COVID-19.

This Springer book provides a perfect platform to submit chapters that discuss the prospective developments and innovative ideas in artificial intelligence and machine learning techniques in the diagnosis of COVID-19.

COVID-19 is a huge challenge to humanity and medical sciences so far as of today, we have been unable to find a medical solution (Vaccine). However, globally we are still managing the use of technology for our work, communications, analytics, and predictions with the use of advancement in data science, communication technologies (5G & Internet), and AI. Therefore, we might be able to continue and live safely with the use of research in advancements in data science, AI, Machine learning, Mobile apps, etc. until we could find a medical solution such as a vaccine.

There are urgent needs globally to understand how to tackle this challenge. In terms of computing and multimedia research, scientists can offer insights, recommendations and new discoveries, which may offer positive impacts and findings related to the causes, cure and analysis of treatment. The recent diagnosis of COVID-19 is based on real-time reverse-transcriptase polymerase chain reaction (RT-PCR) and regarded as the gold standard for confirmation of infection. It has already been widely recognized that advanced AI and Data Science techniques can potentially have a substantial role in streamlining and accelerating the diagnosis of COVID-19 patients, offering high-quality research outputs and accurate predictive modeling. Therefore, this requires pioneering methods such as deep learning, artificial intelligence and computational intelligence since they are highly important.

Together with innovative multimedia techniques, innovative AI and Data Science for COVID-19 can provide added values for scientists. In this book/book chapter, we seek high-quality and unpublished work based on pioneering AI, Data Science and multimedia techniques and findings.

During this COVID-19 crisis, there have been a number of privacy and security issues of personal details and this can be securely managed with the use of smart contracts in intelligent technologies using pioneering AI and Data Science techniques.

This Springer book will be useful for readers and researchers to apply techniques, methods, algorithms, and application of AI and Data Science methods/techniques for further advancements of research.

Topics of interests (but not limited to):

• AI-driven medical imaging (including chest X-ray and CT) analysis for COVID-19
• AI-driven histopathology analysis for COVID-19 diagnosis
• Bioinformatics for COVID-19 subtype rational drug design
• Deep learning-based treatment evaluation and outcome prediction
• AI-based care pathways planning for comorbid patients
• Deep Learning for COVID-19 treatment, and prognosis
• Sensor informatics for monitoring COVID-19 infected patients
• Artificial intelligence in COVID-19 drug discovery and development
• Advanced Data Science techniques in COVID-19 analysis
• Knowledge representation in COVID-19 analysis
• Machine learning for COVID-19 tracking and prediction models
• Computer vision in COVID-19-related medical imaging
• Artificial intelligence methods in COVID-19 patient tracking or monitoring
• Security, privacy and Blockchain methods for COVID-19 research
• Evidence-based reasoning and correlation vs. causality analysis for COVID-19
• Social media security and forensics in COVID-19 risk management
• Predictive Analytics in COVID-19 risk profiling
• AI-driven exploration of susceptibility and infection in humans
• Pattern recognition in COVID-19 risk analysis
• Applications of the Internet of Things in COVID-19
• Artificial intelligence methods in hospital management during an epidemic or pandemic
• Real-world solutions and case studies involved in scientific contributions.

Submission deadline: 1 Aug 2021 (or as early as possible)
Notification Due: 30 Aug 2021 (or as early as possible)
Final Version: 14 Sep 2021 (or as early as possible)

Recommendations for submissions:
- We welcome papers of all types but prefer technical papers, or papers with scientific

processes, steps, methodology, results and analysis.
- There are no fixed numbers of references, but around 30 references or more or so.
- Around 6,000 - 11,000 words on average per chapter (excluding references).
- Please use Harvard APA for referencing, and also in the main body, such as Chang (2021) to start, or (Chang, 2021) at the end of the sentence.
- Demonstrations of the novelty and new findings are important.


Prof. Victor Chang (Lead), Teesside University, UK. Email: victorchang.research at gmail.com

Dr. Harleen Kaur, Jamia Hamdard, India. Email: harleen.unu at gmail.com

Dr. Simon Fung, University of Macau, Macau(Macao), China. Email: ccfong at umac.mo

More information about the hpc-announce mailing list